Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive. reading time 2 minutes To treat acute pain, doctors in the U ...

In a letter to the FDA, the American Society of Anesthesiologists has addressed public health concerns associated with the use of equianalgesic opioid conversion tables and has recommended a staged ...

A new experimental painkiller has shown promise in dulling or eliminating pain without the addictive qualities exhibited by today's most popular opioids. The drug also sidesteps common opioid side ...

The spread of illegally manufactured fentanyl has driven overdose deaths to unprecedented levels in the United States and ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

An FDA advisory panel voted in favor of approving the drug in early October. The FDA announced on Friday that it would side with its advisory panel by approving a new opioid drug, called Dsuvia, ...

Last week, the Trump administration released a five-step plan to address the country’s opioid addiction crisis. The administration’s new drug czar’s plan focuses largely on attempts to prevent ...

Christopher Julian's opioid journey is familiar to many Americans. He was prescribed painkillers as a teenager for a series of sports injuries. He said the doctor never warned him they could be ...